Press Releases Related News

Lygos Appoints Industry Expert Johan van Walsem as COO to Lead Commercial Operations and Manufacturing

Chief Operations Officer van Walsem will lead commercial scale-up of Lygos' specialty biochemicals, starting with the Bio-Malonate™ Platform. BERKELEY, July 25, 2017 (GLOBE NEWSWIRE) -- Lygos, a leading innovator in developing sustainable high-value specialty chemicals, today announced that industry veteran [...]

Calyxt Announces Pricing of $56.0 Million Initial Public Offering

St. Paul, Minn. and New York, NY, July 19, 2017 – Cellectis S.A. and Calyxt, Inc. announced today the pricing of Calyxt’s initial public offering of 7,000,000 shares of its common stock at the initial public offering price of $8.00 per [...]

By | July 25th, 2017|Agriculture, News, Press Releases|

Cellectis Granted Patent for CRISPR Use in T-Cells

July 24, 2017 – New York (N.Y.) – Cellectis (Alternext: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention [...]

By | July 25th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

The Story Behind the Non-Browning Apple: An Interview with Neal Carter

SynBioBeta is hosting Neal Carter at its SynBioBeta San Francisco 2017 Conference in October as the Day 1 Keynote Speaker.  Neal’s experience and knowledge in the applications of biotechnology to the world of food production will make for a compelling [...]

By | July 25th, 2017|Agriculture, Food, News, Press Releases|

BGI Genomics Announces Pricing of Initial Public Offering

SHENZHEN, China, July 14, 2017 — BGI Genomics, an independent division of BGI Group, today announced pricing of its initial public offering of 40.1 million shares at a list price of RMB 13.64 per share. BGI Genomics has been listed on [...]

By | July 23rd, 2017|News, Press Releases|

A vibrant synthetic biology ecosystem has developed in the UK – promising new jobs and valuable technology

London, UK, 21st July 2017 / Sciad Newswire / A survey of synthetic biology company start-ups in the UK is published today by  SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology. The study reveals a vibrant ecosystem sustaining a thriving and [...]

By | July 22nd, 2017|Industry Support, News, Press Releases|